| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Selecta Biosciences (NASDAQ:SELB) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:30 AM.
Here's what investors need to know about the announcement.
Selecta Biosciences missed estimated earnings by 55.56%, reporting an EPS of $-0.14 versus an estimate of $-0.09.
Revenue was down $28.06 million from the same period last year.
Last quarter the company beat on EPS by $0.11 which was followed by a 1.9% drop in the share price the next day.
To track all earnings releases for Selecta Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SELB
